Top Abstract Purchase Related
Home
>
Node
>
Subnode

Advance in studies on pharmacological effect of salidroside on nervous system diseases

Xie, H.; Zhu, D.-h.

Zhongguo Zhong Yao Za Zhi 37(17): 2505-2509

2012

ISSN/ISBN: 1001-5302
PMID: 23236741
Document Number: 663875
Salidroside is an extract from Rhodiola crenulata as well as one of major active constituents. In studies of recent years, salidroside showed multiple effects in protecting nerves, scavenging free radicals, regulating central nervous system neurotransmitter, increasing the ability to promote nerve repair and modulating of apoptosis-related gene expression. Hence, it is expected to be applied in treating degenerative nerve diseases and brain ischemic diseases. This essay summarizes studies on pharmacological effects of salidroside on nerve system diseases, providing reference for further studies, development and application of R. crenulata.

Document emailed within 1 workday
Secure & encrypted payments

Jabłoński, J. 1975: Pharmacological and histochemical studies of antiglaucomatous drugs exerting an effect on the eye's sympathetic nervous system Klinika Oczna 45(7): 779-784
Hirotsu, I.; Kihara, T.; Nakamura, S.; Hattori, Y.; Hatta, M.; Kitakaze, Y.; Takahama, K.; Hashimoto, Y.; Miyata, T.; Ishihara, T. 1988: General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system Arzneimittel-Forschung 38(10): 1398-1409
Khodos, K.G.; Kondakova, T.A. 1978: Analysis of pathoanatomic data at Irkutsk Clinic for nervous system Diseases on infectious diseases of the nervous system over 20-year period (1956--75) Klinicheskaia Meditsina 56(9): 84-88
Yanaura, S.; Abe, Y.; Iwase, H.; Motoashi, Y.; Mineo, K. 1973: Pharmacological studies of 1,3-diphenyl-5-(2-dimethyl amino propionamide) pyrazole HCL (AP-14) with special reference to its action on the central nervous system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 69(5): 679-687
Hayashida, Y.; Maekawa, S.; Maeda, H.; Iwashita, H. 1985: Nursing of refractory nervous system diseases--case studies Nursing Technique 31(12): 1640-1645
Ridet, J.L.; Perre, J.; Foncin, J.F. 1991: The transition zone of the central nervous system-peripheral nervous system of the adult rat; ultrastructural and immunocytochemical studies: a new function of the astroglia? Journal für Hirnforschung 32(6): 761-764
Kacki, J.; Rafalowska, J.; Tomankiewicz, Z.; Wysocki, P. 1975: Usefulness of volumetric studies in the evaluation of respiratory efficiency in nervous system diseases Neurologia i Neurochirurgia Polska 9(3): 355-360
Wasilewski, R.; Rubach, K.; Bortnowska, M. 1972: Effect of tardokrein in vascular diseases of the nervous system Neurologia i Neurochirurgia Polska 6(5): 855-860
Bernacka, I.; Buczko, W.; Wiśniewski, K. 1981: Further studies on the effect of fibrinopeptides a and B on the central nervous system Polish Journal of Pharmacology and Pharmacy 33(4): 407-414
Yang, Z.-H.; Mei, C.; He, X.-H.; Sun, X.-B. 2013: Advance in studies on chemical constitutions, pharmacological mechanism and pharmacokinetic profile of dalbergiae odoriferae lignum Zhongguo Zhong Yao Za Zhi 38(11): 1679-1683
Sińczuk-Walczak, H. 1992: Current state of studies on the effect of organic solvents on the nervous system Medycyna Pracy 43(6): 543-548
Wender, M.; Owsianowski, M.; Zwyrzykowska, E.; Purolowa, J. 1982: Nervous system diseases in large-city population. II. Effect of occupational factors Medycyna Pracy 33(1-3): 45-50
Tanaka, S.; Kawashima, K.; Nakaura, S.; Nagao, S.; Kuwamura, T. 1971: Studies on pharmacological effect of pipethanate. II. Effect of pipethanate on respiration, circulation system and smooth muscle Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 89: 54-58
Iadgarov, I.S. 1983: Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 83(12): 1792-1796
Takai, A.; Hirai, S.; Watanabe, I.; Hiraiwa, T.; Abe, N. 1977: Pharmacological studies on a new penicillin group antibiotic, sodium 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanate (T-1220). I. Effect on central and peripheral nervous systems Japanese Journal of Antibiotics 30(8): 529-542
Kaneko, T.; Katsu, K.; Fujimoto, M.; Yamauchi, H.; Algate, D.R.; Beard, D.J.; Jobling, C.M.; Munt, P.L. 1993: Pharmacological effects of cefclidin on the central nervous system Japanese Journal of Antibiotics 46(1): 18-30
Popoviciu, L.; Asgian, B.; Fagarasanu, M.; Dulau, E.; Sandru, E. 1970: Clinical, electroencephalographic and polygraphic studies of sleep in spasmophilia. Relation of spasmophilia to epilepsy, organic diseases of the nervous system, and neuroses Revue Neurologique (Paris) 123(4): 266-267
Guiol, C.; Ledoussal, C.; Surgé, J.M. 1993: Pharmacological properties of a new fluoroquinolone on the central nervous system in rodents Arzneimittel-Forschung 43(1): 56-60
Phan-Ba, R.; Scuvée-Moreau, J.; Seutin, V. 2008: Pharmacological strategies in the modulation of central nervous system activity Revue Medicale de Liege 63(5-6): 238-244
Loizzo, A.; Caroli, S.; De Maria, G.; Ortolani, E. 1986: A pharmacological analysis of aluminium effects on the central nervous system Annali Dell'istituto Superiore di Sanita 22(2): 703-708